China has overtaken India as one of the fastest-growing locations for drug trials, in a fresh sign of the importance of the world’s most populous country to the pharmaceutical industry.

An analysis by the Financial Times of data on www.clinicaltrials.gov, one of the most comprehensive websites where researchers register their studies, shows that China has 274 clinical trials under way, compared with 260 in India.